Sprouts Farmers Market, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Sprouts Farmers Market, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	4,046	4,665	5,207	5,635	6,469	6,100	6,404	6,837	7,719	8,806
Cost of revenue	2,683	3,098	3,460	3,740	4,089	3,891	4,056	4,316	4,778	5,390
Gross profit	1,363	1,567	1,747	1,895	2,379	2,209	2,349	2,522	2,941	3,416
Selling, general and administrative	1,072	1,246	1,404	1,550	1,864	1,748	1,856	2,000	2,291	2,575
Operating income	213	226	223	217	392	334	358	350	504	686
Interest expense	14.8	21.2	27.4
Other non-operating income	0.45	0.63	0.32
Pre-tax income	199	206	196	196	377	322	349	344	507	689
Income tax	74.3	47.1	37.3	46.5	89.4	78.2	88.1	84.9	126	165
Net income	124	158	159	150	287	244	261	259	381	524
EBITDA	294	323	334	340	518	460	485	488	645	844
EPS, basic	0.84	1.17	1.23	1.25	2.44	2.12	2.41	2.53	3.79	5.36
EPS, diluted	0.83	1.15	1.22	1.25	2.43	2.10	2.39	2.50	3.75	5.31
Shares, basic (weighted)	147	135	129	119	118	115	108	102	100	97.7
Shares, diluted (weighted)	150	138	130	120	118	116	109	103	101	98.7

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	12.5	19.5	1.59	85.3	170	245	293	202	265	257
Receivables	25.2	25.9	40.6	15.7	14.8	21.6	16.1	30.3	30.9	65.2
Inventory	204	230	264	276	254	265	311	323	343	427
Other current assets	0.46	0.45	0.56	0.56	0.56	0.56	0.77	0.77	0.77	0.54
Total current assets	264	300	334	388	466	568	674	604	676	810
Property, plant and equipment	605	713	766	742	727	716	722	799	895	1,085
Lease right-of-use assets				1,028	1,045	1,072	1,107	1,323	1,467	1,653
Goodwill	368	368	368	368	369	369	369	382	382	382
Intangible assets	198	196	195	185	185	185	185	208	208	208
Other non-current assets	5.52	4.78	12.5	11.7	14.7	13.5	14	12.3	13.2	20.7
Total assets	1,440	1,582	1,676	2,723	2,806	2,923	3,070	3,327	3,641	4,159
Accounts payable	158	119	120	123	139	146	173	180	213	291
Accrued liabilities	32.9	45.6	134	136	143	156	151	165	217	304
Total current liabilities	259	300	310	417	496	513	522	547	680	871
Long-term debt	255	348	453
Lease liabilities				1,079	1,070	1,096	1,145	1,400	1,520	1,682
Other non-current liabilities	116	131	153	41.5	40.9	36.3	36.3	36.3	38.3	40.3
Total liabilities	767	931	1,086	2,141	1,925	1,963	2,024	2,179	2,319	2,756
Total debt	255	348	453			250	250	125
Paid-in capital	597	621	657	671	687	705	726	775	808	842
Retained earnings	75.5	30.6	-69.2	-84.4	203	259	320	374	514	561
Other comprehensive income		-0.78	1.13	-4.68	-8.47	-3.76	0
Shareholders' equity	673	651	589	582	881	960	1,046	1,149	1,322	1,403
Total equity	673	651	589	582	881	960	1,046	1,149	1,322	1,403
Total liabilities and equity	1,440	1,582	1,676	2,723	2,806	2,923	3,070	3,327	3,641	4,159
Shares outstanding	140	133	125	118	118	111	105	101	99.3	95.9

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	124	158	159	150	287	244	261	259	381	524
Depreciation and amortization	80.7	97	111	123	127	126	127	138	140	158
Stock-based compensation	13.4	14.2	14.5	8.95	14.3	15.9	16.6	18.9	28.4	31.1
Deferred income tax	20.7	7.8	23.3	-0.22	3.72	-0.18	3.23	-4.92	10.7	7.42
Change in receivables	-4.8	-4.92	-7.67	36.1	26	16.9	13.4	3.17	30	27.2
Change in inventory	-39	-25.1	-34.8	-11.6	21.8	-11.4	-45.2	-10.9	-20.1	-83.8
Change in payables	16	39.2	12.2	9.42	20.2	4.52	13.4	12.2	28	11.2
Cash from operations	254	310	294	355	494	365	371	465	645	716
Capital expenditures	-181	-199	-177	-183	-122	-102	-124	-225	-230	-248
Acquisitions						0	0	-13	0	0
Cash from investing	-181	-199	-177	-183	-122	-102	-124	-238	-230	-248
Stock issued	2.74	9.3	21.8	4.88	1.34	2.17	5.04	11.5	4.89	2.61
Share buybacks	-294	-203	-258	-176	0	-188	-200	-203	-228	-472
Cash from financing	-197	-104	-135	-87.4	-287	-187	-199	-318	-351	-474
Net change in cash	-124	7.01	-17.2	84.5	84.7	75.6	48.2	-91.3	63.3	-6.32
Free cash flow	73.3	111	117	172	372	262	247	240	415	468
Interest paid	14.5	20.8	27.1	20.3	14.8	11.4	11.1	12.6	5.01	1.81
Income taxes paid	46.1	33.5	15.5	44.6	94.8	82.9	93.4	96.6	102	120

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 28, 2026; growth uses fiscal years. Valuation uses the share price of $62.49 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	38.7%	Gross profit / revenue.
Operating margin	7.4%	Operating income / revenue.
EBITDA margin	9.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	7.5%	Pre-tax income / revenue.
Net margin	5.6%	Net income / revenue.
FCF margin	4.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	7.5%	Cash from operations / revenue.
Effective tax rate	25.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	33.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	11.6%	Net income / average total assets.
Return on invested capital (ROIC)	39.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	29.4%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.5%	Capital expenditures / revenue.
D&A / revenue	1.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	14.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	11.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	6.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	16.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	13.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	7.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	36.0%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	24.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	11.9%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	30.9%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	20.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	10.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	37.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	26.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	12.7%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	41.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	30.5%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	16.9%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	11.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	24.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	7.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	12.8%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	23.7%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	4.7%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	6.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	10.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	9.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	14.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	10.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	8.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-2.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-3.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-3.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.99x	Current assets / current liabilities.
Quick ratio	0.37x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.29x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	65.4%	Total liabilities / total assets.
Working capital	-$6.5M	Current assets - current liabilities.
Goodwill and intangibles / assets	13.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$910.9M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	2.08x	Revenue / average total assets.
Fixed asset turnover	7.60x	Revenue / average property, plant and equipment.
Inventory turnover	12.6x	Cost of revenue / average inventory.
Days inventory	29 days	365 x average inventory / cost of revenue.
Receivables turnover	137x	Revenue / average receivables.
Days sales outstanding	3 days	365 x average receivables / revenue.
Days payables	18 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	14 days	Days inventory + days sales outstanding - days payables.
FCF conversion	71.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	47.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.33	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$95.37	Revenue / diluted weighted shares.
FCF per share	$3.78	Free cash flow / diluted weighted shares.
Operating cash flow per share	$7.15	Cash from operations / diluted weighted shares.
Book value per share	$16.01	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$9.72	Tangible book value / shares outstanding.
Cash per share	$2.39	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	109.2%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$5.83B	Share price x shares outstanding.
Enterprise value	$5.60B	Market cap + total debt - cash - short-term investments.
P/E	11.6x	Market cap / net income. Only when net income is positive.
P/S	0.65x	Market cap / revenue.
P/B	3.88x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	6.40x	Market cap / tangible book value, when positive.
P/FCF	16.3x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	8.64x	Market cap / cash from operations, when positive.
EV/Sales	0.62x	Enterprise value / revenue.
EV/EBIT	8.36x	Enterprise value / operating income, when both are positive.
EV/EBITDA	6.69x	Enterprise value / EBITDA, when both are positive.
EV/FCF	15.7x	Enterprise value / free cash flow, when both are positive.
FCF yield	6.1%	Free cash flow / market cap.
Earnings yield	8.6%	Net income / market cap (the inverse of P/E).
Shareholder yield	6.7%	(Dividends paid + share buybacks) / market cap.
PEG	0.38x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Sprouts Farmers Market, Inc.'s revenue in fiscal 2025?

Sprouts Farmers Market, Inc. reported revenue of $8.81B for fiscal 2025, 14.1% higher than the year before.

Was Sprouts Farmers Market, Inc. profitable in fiscal 2025?

Yes. Net income was $523.7M, a net margin of 5.9%.

How much free cash flow did Sprouts Farmers Market, Inc. generate in fiscal 2025?

Cash from operations of $716.0M minus capital expenditures of $248.3M left free cash flow of $467.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Sprouts Farmers Market, Inc.